Search Results - "Terkieltaub, Dov"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2

    Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: Safety and antiviral properties by Galun, Eithan, Eren, Rachel, Safadi, Rifaat, Ashour, Yaffa, Terrault, Norah, Keeffe, Emmet B., Matot, Edith, Mizrachi, Sara, Terkieltaub, Dov, Zohar, Merav, Lubin, Ido, Gopher, Judith, Shouval, Daniel, Dagan, Shlomo

    Published in Hepatology (Baltimore, Md.) (01-03-2002)
    “…Treatment of chronic hepatitis B virus (HBV) infection with interferon alfa and lamivudine is characterized by lack of viral clearance, loss of response, or…”
    Get full text
    Journal Article
  3. 3

    Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia by Idelevich, Pavel, Elkeles, Adi, Okon, Elimelech, Kristt, Don, Terkieltaub, Dov, Rivkin, Ilia, Bruchim, Ilan, Fishman, Ami

    Published in Diagnostic pathology (11-11-2010)
    “…A persistent goal of oncologic histochemistry is to microscopically identify neoplasia tinctorially. Consequently, the newly developed CellDetect® staining…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A novel urine cytology stain for the detection and monitoring of bladder cancer by Davis, Noa, Mor, Yoram, Idelevich, Pavel, Terkieltaub, Dov, Ziv, Vivi, Elkeles, Adi, Lew, Sylvia, Okon, Elimelech, Laufer, Menachem, Ramon, Jacob, Kedar, Daniel, Baniel, Jack, Yossepowitch, Ofer

    Published in The Journal of urology (01-12-2014)
    “…CellDetect® is a unique platform technology comprising a proprietary plant extract and 3 dyes that enables color discrimination between malignant (red) and…”
    Get more information
    Journal Article
  6. 6

    Screening for cervical neoplasia: A community-based trial comparing Pap staining, human papilloma virus testing, and the new bi-functional celldetect® stain by Idelevich, Pavel, Kristt, Don, Schechter, Eduardo, Lew, Sylvia, Elkeles, Adi, Terkieltaub, Dov, Rivkin, Ilia, Bruchim, Ilan, Fishman, Ami

    Published in Diagnostic cytopathology (01-12-2012)
    “…Although cytological screening for cervical neoplasia has lowered mortality rates, current screening methods are plagued by sub‐optimal sensitivity and/or…”
    Get full text
    Journal Article
  7. 7

    Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: Safety and antiviral activity by Galun, Eithan, Terrault, Norah A, Eren, Rachel, Zauberman, Arie, Nussbaum, Ofer, Terkieltaub, Dov, Zohar, Meirav, Buchnik, Rachel, Ackerman, Zvi, Safadi, Rifaat, Ashur, Yaffa, Misrachi, Sara, Liberman, Yael, Rivkin, Ludmila, Dagan, Shlomo

    Published in Journal of hepatology (01-01-2007)
    “…Abstract Background/Aims: HCV-AB68, a human monoclonal antibody against the envelope protein of hepatitis C virus (HCV), neutralizes HCV in cell-culture and in…”
    Get full text
    Journal Article
  8. 8

    Novel dual-function CellDetect.sup.[R] .sup.staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia by Idelevich, Pavel, Elkeles, Adi, Okon, Elimelech, Kristt, Don, Terkieltaub, Dov, Rivkin, Ilia, Bruchim, Ilan, Fishman, Ami

    Published in Diagnostic pathology (11-11-2010)
    “…Background A persistent goal of oncologic histochemistry is to microscopically identify neoplasia tinctorially. Consequently, the newly developed…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11